ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 712733 Null 0.0304779558345019 0.13972469
NSC 742544 Naphth[1',2':4,5]imidazo[1,2-a]pyridine-5,6-dione, 9-chloro- 0.0304779558345019 0.25920845
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0304779558345019 0.23421181
NSC 748404 Null 0.0304779558345019 0.19408664
NSC 109451 Null 0.0386895225700407 0.062748943
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0386895225700407 0.33999407
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0386895225700413 0.53860018
NSC 169774 Bromocriptine methanesulfonate 0.0386895225700413 0.11912696
NSC 245456 Naphthalene, 2,3-dimethoxy-6-(2-nitroethenyl)- 0.0386895225700413 0.030578943
NSC 295501 Camptothecin Derivative 0.0386895225700413 0.70593527
Total:49  Current:34    [First] [Prev] [Next] [Last]